Results 31 to 40 of about 267,865 (313)
Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
Journal of Translational Medicine, 2019 Background Proprotein convertase subtilisin/kexin 9 (PCSK9) has been proposed as a novel target for coronary artery disease (CAD). Familial hypercholesterolemia (FH) is characterized by high prevalence of CAD and major cardiovascular events (MACEs ...
Ye-Xuan Cao +10 more
doaj +1 more source
Psoriasis and Dyslipidemia [PDF]
Materia Socio Medica, 2015 Psoriasis is a chronic skin ailment, which can be connected with other ailments including dyslipidemia.Research included 70 patients affected by psoriasis. Both genders, above 18 years of age. Average age of the respondents was 47.14 (SD= ±15.41), which consisted of 36 men (51.43%) and 34 women (48.57%). The average duration of psoriasis was 15.52 (SD=
Salihbegovic, Eldina Malkic +7 more
openaire +2 more sources
Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism [PDF]
Endocrine Connections, 2022 Hypothyroidism is often associated with elevated serum levels of total cholesterol, LDL-C and triglycerides. Thyroid hormone (TH) affects the production, clearance and transformation of cholesterol, but current research shows that thyroid-stimulating hormone (TSH) also participates in lipid metabolism independently of TH.
Huixing Liu, Daoquan Peng
openaire +2 more sources
Lipids in Health and Disease, 2018 Background Achievement of low-density lipoprotein cholesterol (LDL-C) goal is the most important for the patients with atherosclerotic cardiovascular diseases (ASCVD) who received lipid-lowering therapy.
Na-Qiong Wu +10 more
doaj +1 more source
Diabetes Therapy, 2016 Diabetes mellitus is associated with a considerably increased risk of premature atherosclerotic cardiovascular disease. Intensive glycemic control has essentially failed to significantly improve cardiovascular outcomes in clinical trials. Dyslipidemia is common in diabetes and there is strong evidence that cholesterol lowering improves cardiovascular ...
Schofield, Jonathan D +4 more
openaire +2 more sources
Scientific Reports, 2017 We investigated simultaneously traditional and novel lipid indices, alone or in combination, in predicting coronary severity assessed by Gensini score (GS) in 1605 non-lipid-lowering-drug-treated patients undergoing coronary angiography.
Sha Li +13 more
doaj +1 more source
Cardiovascular Diabetology, 2019 Background The aim of the present study is to examine the effects of free fatty acids (FFAs) on major cardiovascular events (MACEs) in patients with stable coronary artery disease (CAD) and different glucose metabolism status.
Jing-Lu Jin +11 more
doaj +1 more source
Arquivos Brasileiros de Cardiologia, 2016 Lipoproteins constitute a set of proteins and lipids, organized to facilitate the transport of lipids through blood plasma. Elevated or decreased levels of these lipoproteins may be related to genetic alterations in 40% to 60% of cases.1 This fact explains why it is common to find lipid abnormalities in several members of the same family.
García-Giustiniani, Diego +1 more
openaire +4 more sources
BMC Endocrine Disorders, 2020 Background Previous studies have suggested that patients with diabetes mellitus (DM) have higher prevalence of atherosclerotic cardiovascular disease (ASCVD), and plasma levels of free fatty acids (FFAs) are a useful marker for predicting ASCVD.
Ming-Hua Zhang +9 more
doaj +1 more source
Treatment of dyslipidemia [PDF]
F1000Prime Reports, 2014 Atherosclerotic cardiovascular disease (including coronary heart disease, stroke and peripheral arterial disease) is the leading cause of death globally. Abnormal blood lipids (dyslipidemia), smoking, and high blood pressure are responsible for more than 75% of cases.
Tonkin, Andrew, Byrnes, Allison
openaire +2 more sources